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Aim: To explore the views of non-morbidly obese people (BMI 30–40 kg/m2) with type
2 diabetes regarding: (a) the acceptability of bariatric surgery (BS) as a treatment
for type 2 diabetes, and (b) willingness to participate in randomised controlled
trials comparing BS versus non-surgical intervention. Background: Despite weight
management being a key therapeutic goal in type 2 diabetes, achieving and sustaining
weight loss is problematic. BS is an effective treatment for people with morbid obesity
and type 2 diabetes; it is less certain whether non-morbidly obese patients (BMI
30–39.9 kg/m2) with type 2 diabetes benefit from this treatment and whether this
approach would be cost-effective. Before evaluating this issue by randomised trials,
it is important to understand whether BS and such research are acceptable to
this population. Methods: Non-morbidly obese people with type 2 diabetes were
purposively sampled from primary care and invited to participate in semi-structured
interviews. Interviews explored participants’ thoughts surrounding their diabetes and
weight, the acceptability of BS and the willingness to participate in BS research. Data
were analysed using Framework Analysis.
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Introduction
Obesity is one of the leading global risks for
mortality worldwide (World Health Organisation,
2009). The National Centre for Health and Statistics
(Ogden and Carroll, 2010) indicates that in the
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United States adult obesity rose from 23% in
1988–1994 to 34% in 2007–2008. Similar trends
have been reported in other developed countries,
with the United Kingdom having the highest
obesity rates of all European countries [Organisa-
tion for Economic Co-Operation and Development
(OECD), 2010; The NHS Information Centre for
Health and Social Care, 2011]. Prevalence and
associated burden of morbidity such as type 2 dia-
betes will continue to rise (Adams et al., 2006;
Holman et al., 2011; Wang et al., 2011) without
effective intervention.
Weight reduction is a key therapeutic goal in the
management of obese patients with type 2 diabetes
(Williamson et al., 2000; Holman et al., 2011), as it
decreases fat mass, improves glycaemic control and
reduces complications (Buchwald et al., 2009;
American Diabetes Association, 2011). However,
many of the weight management interventions for
type 2 diabetes have limited effect (Norris et al.,
2005; Bailey, 2011). Bariatric surgery (BS) is one
strategy to achieve greater and more sustained
weight loss. Buchwald et al.’s (2009) meta-analysis
of 621 studies found that diabetes was resolved in
78% of people, which rose to 86% when including
those with improved diabetes control. The UK
National Bariatric Surgery Registry published
similar data (Welbourn et al., 2010). Before surgery,
28% of BS patients had type 2 diabetes, although at
two years of post-surgical follow-up, glucose toler-
ance had improved and diabetes had resolved in
86% of these patients (Welbourn et al., 2010).
Mingrone et al.’s (2012) randomised controlled trial
(RCT) compared medical therapy versus surgery in
60 morbidly obese patients with type 2 diabetes, and
found that remission had occurred in 75% and 95%
of patients in the gastric bypass and biliopancreatic
diverson groups, respectively, in comparison with no
remissions in the medical therapy group. Conse-
quently, a growing body of evidence supports BS as
an intervention for improving and/or correcting
type 2 diabetes. Although evidence suggests pro-
mising results, most research investigates the effects
of BS in people who are morbidly or severely obese
(BMI> 40 kg/m2). However, many patients with
type 2 diabetes have BMI 30–39 kg/m2, and given
the limited effectiveness of non-surgical strategies,
there is a need to assess the role of BS in such
patients. One small RCT involving 60 patients
has indicated that the benefits associated with BS
also apply in patients with BMI 30–40 kg/m2
(Dixon et al., 2008). At two years, diabetes
remission rates were 73% in surgical arm and
27% in the non-surgical, with 62.5% versus 4.3%
loss of excess weight, respectively (Dixon et al.,
2008). However, this study was relatively small and
needs replication. The need for further research is
particularly important for countries such as the
United Kingdom, which allocate health provision
on the basis of best available evidence. In the
United Kingdom, current guidelines from the
National Institute for Health and Clinical Excellence
(NIHR, 2006) only recommend BS for people
whose BMI is >35–39 kg/m2 in the presence of
weight-related conditions, including type 2 dia-
betes. Moreover, with considerable geographic
variation in eligibility criteria between primary
care trusts (Haslam, 2010), a stronger evidence
base is required to inform decisions on bariatric
surgery (BS) provision.
Although evidence into the effectiveness of BS as
a treatment for non-morbidly obese people with type
2 diabetes is needed, understanding the patients’
perspectives of BS as an appropriate intervention to
control their weight and improve their glycaemic
control is vital, providing a sense of population
interest in BS and factors that may enhance recruit-
ment to future trials. The evidence exploring patient
motivations for undergoing BS suggest the desire to
reduce co-morbidities, enhance quality of life and
regain a sense of control are key motivating factors
(Ogden et al., 2006; Munoz et al., 2007; Karmali et al.,
2011). However, just as RCTs investigating BS tend
to study morbidly obese populations, qualitative
studies into BS usually focus on patients with higher
BMIs and largely explore the views of individuals
who have already undergone surgery, thereby
omitting the perspectives of those unwilling to
consider BS or the non-morbidly obese.
The aim of this study was to explore (a) the
acceptability of BS as a treatment strategy, and
(b) willingness to participate in an RCT comparing
BS with a non-surgical strategy, within this group, to
elucidate factors associated with willingness to
consider BS and participate in research.
Methods
Sampling and recruitment
Five general practitioner (GP) clinics (four in
the South of England, one in the North) were
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involved in identifying and inviting eligible
patients. GP practices were chosen to give a
diversity of catchment areas in terms of urban–
rural and geographical location, deprivation and
ethnicity. Table 1 provides the study inclusion and
exclusion criteria. Patients were purposively
sampled on the basis of demographic information:
age, sex, BMI, ethnicity and duration of type 2
diabetes. Data collection ended when no new
responses were revealed by further interviewing
and data saturation was judged to have been
achieved.
Data collection
Data were collected using semi-structured
interviews, which followed an interview guide
developed by the study team in consultation with
two lay advisors. The guide consisted of open-
ended questions relating to one of four topic
areas: diabetes and diabetes management, weight
and weight management, weight loss surgery and
participating in weight loss research.
BS was discussed towards the end of the
interview, and in order to ensure that participants
were informed enough to comment on their
willingness to consider BS, interviewees were
provided with information on the advantages and
disadvantages of surgery (Table 2). To capture
participants’ pre-interview stance, interviewees
were first asked about their knowledge of and
willingness to consider BS before any information
was given. This was then re-evaluated once par-
ticipants had been given the information.
Interviews lasted 40–90 min and were digitally
recorded and transcribed verbatim. Participants
were either interviewed at their GP practice
(n5 7) or their own home (n5 15), depending
on their preference, and completed a brief
demographic questionnaire that recorded: age, sex,
ethnicity, educational level, occupation and social
circumstances. From the outset, participants were
attributed pseudonyms that were used throughout
Table 1 Study inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Aged between 18 and 74 years Recent acute coronary heart disease
Diagnosis of type 2 diabetes for 2 years or more Severe respiratory disease
BMI 30–39.9 kg/m2 Recent cancer
BMI 27.5–29.9 kg/m2 (lower BMI range for South
Asian people only)
Neurological disorders
Severe mental health conditions
Other health reason the GP felt would prevent inclusion
Table 2 Bariatric surgery pros and cons
Advantages Disadvantages
Improved life expectancy Increased short-term risk of
death (low risk 1 in 300 to
1 in 1000 for gastric bypass
and band, respectively)
Improved diabetes/
possible remission
Risk of post-operative
complications
Hospital stay (1–4 days)
Improved quality of life
Time off work (1–4 weeks)
Less need for medication
Need for lifelong vitamin
and mineral supplements
Substantial weight loss
Possible weight regain
Improved fitness
Possible development of
loose skin folds
Altered body appearance
Intolerance to certain foods
More control over eating
behaviour
May restrict eating out
Possible diarrhoea or loose/
foul smelling stools (gastric
bypass)
Risk of reoperation (one in
five over 5 years for gastric
band)
The above table was developed on the basis of available
literature and author expertise, particularly consultant
surgeons J.B. and R.W. Study lay advisors commented
on content. R.H.S. sat in weight loss surgery clinic
consultations and received training from J.B. to ensure that
information provision during interviews was proficient.
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the study as identifiers, to protect participant
anonymity and maintain confidentiality.
Data analysis
Interviews were analysed in accordance with
Framework Analysis as described by Ritchie
and Spencer’s (1994) ‘Framework’ approach. This
method consists of five steps:
1) Familiarisation: the analysts read through
transcripts and notes, pull out key ideas and
start to identify recurrent themes.
2) Thematic framework: a framework is con-
structed on the basis of the original research
aims and the recurrent themes identified
during the familiarisation process.
3) Indexing: the thematic framework is applied
consistently to all data.
4) Charting: data from the original context are
lifted and placed within the appropriate
thematic categories within the framework.
5) Mapping: the final stage in the process is to
interpret and map the range, polarities and
similarities within the data.
Negative case analysis, where instances of dis-
agreement are explored, was also used.
Rigour
During data collection, audio recordings were
transcribed within 1–3 days of the original inter-
views. All team and lay members were sent
transcripts and were invited to comment. This was
to reduce the chance of important issues raised
during interviews being missed or not followed
up. It also aided the team in familiarising them-
selves with the data and in the development of the
framework. Lay members were provided with the
analysis procedure and training and support was
provided where necessary. Before the analysis
began, team members were encouraged to con-
sider their own personal perspectives and how
this could shape their analysis.
Transcripts were divided among the team
(which included lay advisors), with one member,
R.H.S., acting as the primary analyst coding all
transcripts, and collating comments and codes
from other team members. All team members
were provided with training and support on the
analysis procedure. Regular team meetings and
open discussion ensured that the framework
development was transparent and credible.
Results
Sample characteristics
A total of 22 people were interviewed. Table 3
presents the sample demographics. Of the
22 patients, 19 were white British, two were South
Asian and one was white South African. Of the
interviewees, 20 controlled their diabetes with
oral medication, two were insulin dependent.
Perceptions of BS and willingness to
participate in RCT
All participants had some prior awareness of
BS, and there was a commonly expressed per-
ception that BS was for ‘those who are more
grossly obese’ (Valerie, 73 years), ‘a last resort’
(Harry, 71 years) for people who had ‘a real
problem to lose weight’ (Grace, 62 years). It was
clear that none of the participants considered
themselves to fall within the group at which BS
was aimed:
‘I’ve never even thought of it [BS]. I don’t
think I’m that big for me to start going
through stuff like this’
(Ilias, 56 years, anti-BS)
Despite the belief that BS was for larger indi-
viduals, there was variable personal interest.
Some felt BS was absolutely inappropriate for
them, whereas others reported a willingness to
consider BS. Table 4 summarises the interest
expressed towards BS and weight loss research.
All interviewees who were pro-BS or unsure-BS
were open to considering participating in an RCT.
Conversely, those who were anti-BS were largely
unwilling to participate in RCT research, in case
they ‘ended up having surgery’ (Grace, 62 years,
Table 3 Sample demographic information (n5 22)
Demographic Range (median)
Age (years) 47–73 (64)
Sex (male:female) 13:9
BMI (kg/m2) 30–38 (33)
Years diagnosed with type 2 diabetes 3–18 (6)
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anti-BS), and those who did say they would take
part explained that if they were put in the surgery
group they would ‘be walking out’ of the trial
(Bernard, 47 years, anti-BS). Noteworthy, the
four participants underscored in Table 4 had
initially rejected the idea of BS before being
presented with the BS risk and benefit informa-
tion and altered their stance afterwards. Partici-
pants reported having been told that type 2
diabetes was a lifelong condition, believing that
‘once you’ve got diabetes, you’ve got diabetes’
(Ilias, 56 years, anti-BS), and these interviewees
expressed surprised, and in some cases scepticism,
as to whether BS could result in remission of type
2 diabetes.
When discussing the reasons for an inter-
viewee’s particular stance, a number of con-
siderations arose. Disadvantages to surgery such
as increased risk of death, infection, post-operative
complications and the permanent nature of surgery
were all highlighted as off-putting, both by those
not interested in BS and those unsure of BS.
Conversely, some of those interested in BS
reported being less concerned by the above, not-
ing that such risks were to be expected with any
kind of surgery. Two themes emerged as influen-
tial when determining the individual’s stance on
the appropriateness of BS: ‘condition-related life
impact’ and ‘perceived control’.
Condition-related life impact
All patients interviewed recognised the impor-
tance of both diabetes and obesity. However,
despite this recognition, there was great variance
in the extent to which individuals felt their
diabetes or weight was a threat to their own
health and well-being.
Some interviewees reported having adopted a
healthier lifestyle despite being asymptomatic,
with the desire to avoid related complications
or injections being highlighted as motivational.
Conversely, for others, the absence of complica-
tions appeared to reduce the perception of threat
and subsequent desire to adopt healthier life-
styles. Ian (72 years) explained that as he had not
experienced any problems, this, coupled with his
philosophy of ‘never try jumping fences that
aren’t there’, meant that having diabetes did not
motivate him to alter his lifestyle and others
commented comparably. Lack of symptoms was
perceived by some as evidence that their diabetes
was under control and well managed, irrespective
of their weight status or HBA1c.
In contrast, other participants had experienced
complications, which they contextualised in terms
of the impact these complications had on their day-
to-day living. For example, one female respondent
explained that the fatigue she experienced as a
consequence of diabetes diminished her ability to
both plan and attend social events with friends, and
do pastimes such as gardening:
‘I’m putting it down to the diabetes, but the
fact that I wake up extremely tired and
exhausted, and I can’t get through the day,
even though I’ve had a good night’s sleep’
(Felicity, 70 years, unsure-BS)
For some, excess weight was described as
more influential. This was particularly discussed
among those who attributed their own physical
Table 4 Interest towards BS and research [Patient (BMI kg/m2 and treatment)]
Participant stances Would consider BS Would not consider BS Unsure about BS
Would consider RCT Arnold (32/M), Charlotte
(37/M), Joyce (34/M),
Ruth (36/M)
Bernard (34/M), Grace (31/M) Felicity (31/M), Marcus (31/
M), Nathan (38/M), Sophie
(37/M), Phil (38/M)
Would consider
preference trial only
Dennis (31/M), Leonard (30/I),
Harry (30/M), Ian (32/M), Oliver
(38/M), Trevor (32/I), Valerie
(32/M), Sashi (35/M), Ilias (35/M)
No interest in
interventional weight
loss research
Kath (30/M), Edward (31/M)
BS5bariatric surgery; M5oral medication, I5 insulin therapy
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limitations to weight-related health problems,
though aesthetic dissatisfaction was also reported:
‘My weight? Oh, I want to lose it. Oh, I’m
desperate because that would ease the weight
on my knees and therefore I’d be able to
walk further’
(Joyce, 67 years, pro-BS)
‘Well, I’m not too happy with it. You know,
I sometimes look in a mirror and I call
myself all kinds of names, fat so-and-so and
everything else’
(Nathan, 64 years, unsure-BS)
The impact of diabetes and obesity was vari-
able, with only some individuals experiencing
problems. Individuals with no interest in BS, such
as Kath (72 years, anti-BS), Ilias (56 years, anti-
BS) and Oliver (67 years, anti-BS), appeared to
share the characteristic of being relatively
asymptomatic. These individuals felt that neither
their diabetes nor their weight adversely affected
their lives. Given the absence of disease-related
symptoms or functional impairments, this group
of interviewees questioned how BS would be of any
benefit. This inability to perceive potential benefit
was contrasted with the invasive nature of BS and
potential harm associated with surgery and hospi-
talisation. As a result, some concluded ‘if you don’t
need to then don’t bother’ (Ilias, 56 years, anti-BS).
Conversely, where participants reported one or
both conditions to be negatively affecting their lives,
BS was seen as having the potential to convey
benefits and as such, worth considering:
‘It’s [BS] got to improve your fitness, if
you’re not carrying all that weight around.
I put a lot of that down to why I can’t walk
very far without getting out of breath’
(Charlotte, 50 years, pro-BS)
Perceived control
There were individuals such as Valerie (73 years),
Trevor (55 years) and Grace (62 years) who did
feel that their diabetes and weight influenced their
lives and yet felt that BS was inappropriate in
their management. A key difference between these
individuals and other interviewees such as Char-
lotte (50 years), Joyce (67 years), Felicity (70 years)
and Nathan (64 years), who were interested in
BS, was their perception of control. Those feeling
able to alter their situation did not feel that BS
was necessary, whereas those who felt unable to
exert change were more willing to consider BS.
Table 5 compares Trevor and Felicity’s contrasting
situations.
It should be noted that not all participants who
lacked the ability to control their weight were
pro-BS. Indeed, Sophie (63 years, unsure-BS)
described how she would find it difficult to con-
sider BS, as she felt that the diabetes was her
‘fault’ and that she ‘should be able to control it,
I’m a grown woman after all! I’m not an idiot of a
child’. Sophie (63 years, unsure-BS) concluded by
saying that her feelings surrounding her weight
and self-responsibility were ‘almost like a moral
thing’ and that she found it difficult to consider BS
because she felt that she ‘shouldn’t need that [BS]’.
For some, perception of control was informed
by the individual’s expectations of ageing, with
both health problems and increased weight being
associated with growing older. Moreover, whereas
some such as Felicity (73 years, unsure-BS) were
Table 5 Comparative quotes
(1a) Trevor (55 years, anti-BS) on his ability to control
his weight
(1b) Felicity (73 years, unsure-BS) on her ability to lose
weight
Well I was 107 kilos and I am now as of this morning
just over 90, so that’s 17 kilos in just a year.
‘I can’t seem to lose any weight. I have tried several diets.
I’ve even tried not eating, and I just don’t lose an ounce’.
(2a) Trevor (55 years, anti-BS) on his interest in BS (2b) Felicity (73 years, unsure-BS) on her attitude towards BS
I wouldn’t have either of them done (band or bypass).
I hope I stay in control. Who knows in 10 years from
now, you don’t know do you, your circumstances,
but at the moment in my life I feel very much in
control of my body which is a help I think.
‘Because I would really like to lose weight, and if I could be
assured – it’s difficult really to say. I would consider –
I possibly would consider surgery’
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still willing to consider BS, others who were not
unhappy with their situation questioned whether
any benefits derived from BS would be enjoyed for
a sufficient length of time so as to warrant the short-
term inconveniences and increase risk of mortality
associated with undergoing surgery:
‘At my time in life 72, nearly 73 I feel the
improvement isn’t going to be as long term as
for someone in their 30’s, 40’s, 50’s. So I think
the scales come down more on the status quo
rather than wanting to change it by taking
that road’
(Ian, 72 years, anti-BS)
Noteworthy, among those who were not in
favour of BS, some were willing to consider it as
an option in the future if their circumstances were
to change, such as their health worsening con-
siderably or losing control:
‘If somebody turned round to me and said ‘if
you don’t have this operation done [BS],
you’ll be dead in three months’ time’, you
would seriously contemplate it, wouldn’t you,
because you then look at the priority and turn
round and say ‘okay, on balance, I’ll have it
done’ so I think that’s about the only time. It’s
when it comes down to something being critical.
I don’t think that my situation is critical’
(Oliver, 67 years, anti-BS)
‘If I didn’t have the willpower and I was
offered it [BS], yes. I think it’s a great thing to
help people. Well I hope I stay in control.
Who knows in 10 years from now, you don’t
know do you, your circumstances, but at the
moment in my life I feel very much in control
of my body which is a help I think’
(Trevor, 55 years, anti-BS)
Discussion
Previous studies have commonly explored the
perspectives of more severely obese individuals
who have already undergone BS (Ogden et al.,
2006; Munoz et al., 2007; Karmali et al., 2011).
This study is unique, presenting the attitudes of an
under-researched population towards BS; those
who are non-morbidly obese, with type 2 dia-
betes; and those who have not had BS. Key
findings were that some patients considered BS to
be an acceptable intervention, and would con-
sider participating in an RCT. Those interested in
BS had a range of BMIs, suggesting that other
factors also influenced their interest in surgery.
Our findings suggest that both the extent to which
people’s lives are negatively affected by their
weight and/or diabetes, and their perceived control
may be significant.
Those interested in BS and even those unsure
of BS identified beneficial factors associated with
BS, including improved diabetes control,
increased mobility, reduced joint pain, altered
physical appearance and substantial weight loss.
In contrast, those who were not interested in BS
reported being less affected by their weight or
diabetes and as such did not feel BS conveyed any
particular benefits. This suggests that where dia-
betes or weight are perceived to have an impact
on life intolerably, such as imposing restrictions to
participation in valued activities, individuals may
be more likely to consider BS. This supports
previous research into motivations for BS in
populations with higher BMIs (Ogden et al., 2006;
Munoz et al., 2007; Karmali et al., 2011). Given
the current economic climate and funding lim-
itations for health-care interventions, it is most
likely that future studies into the effects of BS in
this population will investigate the economic
benefit of BS for patients who have the highest
absolute risk of adverse outcomes and health-care
costs, including those starting on insulin or with
diabetic complications. As such, it is plausible that
this subgroup of non-morbidly obese patients with
T2DM may identify negative condition-related
impact higher and are more likely to identify a
positive role for BS in their management.
Importantly, some individuals did not perceive
their weight or diabetes to affect their health,
considering their lack of symptom testament to
this. That individuals may not be compelled to
alter their lifestyle or lose weight until sympto-
matic has been reported elsewhere (Murphy and
Kinmonth, 1995; Brown et al., 2002; Matthews et al.,
2009; Zhang et al., 2011). A related issue concerns
the perception that type 2 diabetes is a permanent,
irreversible condition. Some authors note that this
perception may deter patients from implementing
positive lifestyle changes (Murphy and Kinmonth,
1995). Furthermore, it may also prevent such
patients perceiving BS as a potentially appropriate
intervention for type 2 diabetes. Clinicians need to
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be aware that information regarding BS may con-
tradict their patients’ established beliefs surround-
ing the permanency of diabetes and may need to be
targeted educationally.
Negative condition-related impact on life was
not always indicative of interest in surgery. Some
patients did feel their diabetes and/or weight to
be detrimental but were still unwilling to consider
BS. In such cases, the individual’s perception of
control was identified as moderating interest.
Those who felt they were able to exert control
over their weight and/or diabetes seemed less
open to considering BS, as were those who
described being unbothered by their condition. In
contrast, those who felt they were unable to
control their weight and were unhappy about this
seemed likelier to consider BS. This finding
complements work by Ogden et al. (2006), who
found that patients undergoing BS reported
feeling a renewed sense of control. Our findings
suggest an exception to this, where the individual
feels a strong sense of responsibility towards their
own weight and is unable to relinquish control
because of this. This supports Brown et al.’s (2006)
suggestion that high levels of self-responsibility
and consequent embarrassment may deter
patients who are obese from accessing primary
care support for weight management issues, and
underscores its potential to deter patients from
considering BS specifically. In such cases, health
professional recommendation may alleviate the
sense of guilt arising from personal perceptions of
having failed to exert a ‘proper’ degree of self-
control. Age seemed influential to some patients’
attitudes, with some potentially feeling too old to
derive enough benefit to personally justify the
time and effort involved in undergoing BS.
All participants who were in favour or unsure
of BS were willing to consider participating in
RCTs comparing BS with a non-surgical alter-
native. Some participants had altered their stance
after considering the risk and benefit information,
which suggests that the provision of information can
alter perceptions in favour of BS for some indivi-
duals. Conversely, those unwilling to consider BS
were unwilling to participate in RCTs for fear of
being allocated BS. However, most participants
were willing to take part in a preference trial, which
reflected a general interest in weight reduction.
This study followed a robust methodological
design and utilised peer review, multiple coders
and negative case analysis to produce a credible
piece of research. Although the results presented
were derived from a sample whose demographics
adequately represented the sexes and were
diverse in ages, BMI and years diagnosed, having
a predominantly white British sample, most of
whom were orally medicated, was a limitation.
Future research considering other ethnic groups
and treatment regimens may identify further
influential factors, thereby building on this work.
Moreover, the findings presented are suggestive of
factors that influence a patient’s willingness to
consider BS and participate in an RCT. The overall
support for BS needs to be determined in an ade-
quately sized survey, in a representative group of
patients and identified hypotheses tested. The
findings here will guide the development of a
questionnaire survey into patient attitudes towards
BS and willingness to participate in a research trial
comparing BS with a non-surgical intervention.
Conclusion
This study found diverse attitudes towards BS
among non-morbidly obese patients with type 2
diabetes. BS may be an acceptable option to patients
who both experience negative effects as a con-
sequence of their diabetes and/or excess weight, and
struggle with weight/glycaemic control, although age
expectations may also be influential. In contrast,
people who do not perceive their condition (weight
or diabetes) to negatively affect their lives and feel
able to control their weight/diabetes may be less
inclined to consider BS as a viable option. The pro-
vision of adequate, balanced information on BS may
encourage some individuals to re-evaluate their
stance towards BS. Although most would consider
participating in weight management research,
those interested in BS were more willing to con-
sider participating in an RCT.
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